首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌合并甲状腺癌致病因素的研究进展
引用本文:姜欢,赵睿,戴绍春. 乳腺癌合并甲状腺癌致病因素的研究进展[J]. 肿瘤防治研究, 2021, 48(5): 530-536. DOI: 10.3971/j.issn.1000-8578.2021.20.1092
作者姓名:姜欢  赵睿  戴绍春
作者单位:150081 哈尔滨,哈尔滨医科大学附属肿瘤医院超声科
摘    要:甲状腺癌和乳腺癌是女性中最常见的两种恶性肿瘤。甲状腺和乳腺并发肿瘤在临床实践中较为罕见,但近年来这种双重恶性肿瘤的发生率有所增加。以往进行的研究主要集中在对侧乳腺癌发病率可能增加的问题上,而近期在患有乳腺癌的女性中发生甲状腺癌的风险升高引起了广泛关注,具体机制尚未被彻底了解,因此本文就这两种疾病之间的致病因素作一综述,同时评估这些因素在两癌并发中的病因学作用,以为临床实践提供更好的依据。

关 键 词:甲状腺癌  乳腺癌  双原发肿瘤  钠-碘同向转运体  
收稿时间:2020-09-14

Research Progress on Pathogenic Factors of Breast Cancer Combined with Thyroid Cancer
JIANG Huan,ZHAO Rui,DAI Shaochun. Research Progress on Pathogenic Factors of Breast Cancer Combined with Thyroid Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(5): 530-536. DOI: 10.3971/j.issn.1000-8578.2021.20.1092
Authors:JIANG Huan  ZHAO Rui  DAI Shaochun
Affiliation:Department of Ultrasound, Cancer Hospital of Harbin Medical University, Harbin 150081, China
Abstract:Thyroid cancer and breast cancer are two of the most common malignant tumors in women. Concurrent tumors of the thyroid and breast are relatively rare in clinical practice; however, the incidence of such dual malignancies has recently increased. Researches conducted in the past mainly focused on the possible increase in the incidence of contralateral breast cancer, while the increased risk of synchronized thyroid cancer in women with breast cancer has attracted widespread attention recently. The specific mechanism has not been fully understood. This article reviews the pathogenic factors between these two diseases, and evaluates the etiological role of these factors in these double primary cancers, so as to provide a better basis for clinical practice.
Keywords:Thyroid cancer   Breast cancer   Double primary tumors   Sodium iodide symporter (NIS)  
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号